#checkpoint — Thursday, September 24, 2026 (1 items)
| 0 | ℹ |
AIM2 in tregs restrains anti-PD-1 efficacy by reinforcing immune suppression in MC38 colorectal cancer.
(linkinghub.elsevier.com)
|
iScience 2026-09-24 | #cancer #immunotherapy #immunosuppression #immunity #checkpoint |